The fact that the market cap is less than 50 million for a co with so much potential is what surprises me. Why hasn't any of the big pharmas jumped to date to buy it out. I mean 140 million with 15/share is coin change for some of these big pharmas? So, what is the story of shorts who keep shorting it with so much promise? Do they know something?